ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The Tri-Institutional Therapeutics Discovery Institute, a collaboration among three New York City-based academic centers, has launched with $20 million in philanthropic funding. The partnership among Memorial Sloan-Kettering Cancer Center, Rockefeller University, and Weill Cornell Medical College brings together experts in medicinal chemistry, compound screening, and drug development. Medicinal chemistry will take place at labs that are set to open in January at Weill Cornell. The nonprofit institute has partnered with Takeda Pharmaceutical to develop small-molecule drugs.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X